223 related articles for article (PubMed ID: 15121792)
1. Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis.
Mayer K; Goedbloed M; van Zijl K; Nellist M; Rott HD
J Med Genet; 2004 May; 41(5):e64. PubMed ID: 15121792
[No Abstract] [Full Text] [Related]
2. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
[TBL] [Abstract][Full Text] [Related]
3. Recurrent mutation 4882delTT in the GAP-related domain of the tuberous sclerosis TSC2 gene.
Verhoef S; Vrtel R; Bakker L; Stolte-Dijkstra I; Nellist M; Begeer JH; Zaremba J; Jozwiak S; Tempelaars AM; Lindhout D; Halley DJ; van den Ouweland AM
Hum Mutat; 1998; Suppl 1():S85-7. PubMed ID: 9452050
[No Abstract] [Full Text] [Related]
4. A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex.
Khare L; Strizheva GD; Bailey JN; Au KS; Northrup H; Smith M; Smalley SL; Henske EP
J Med Genet; 2001 May; 38(5):347-9. PubMed ID: 11403047
[No Abstract] [Full Text] [Related]
5. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.
Li Y; Inoki K; Guan KL
Mol Cell Biol; 2004 Sep; 24(18):7965-75. PubMed ID: 15340059
[TBL] [Abstract][Full Text] [Related]
6. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.
Zhang Y; Gao X; Saucedo LJ; Ru B; Edgar BA; Pan D
Nat Cell Biol; 2003 Jun; 5(6):578-81. PubMed ID: 12771962
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
Nellist M; Goedbloed MA; Halley DJ
Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
[TBL] [Abstract][Full Text] [Related]
8. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.
Au KS; Rodriguez JA; Finch JL; Volcik KA; Roach ES; Delgado MR; Rodriguez E; Northrup H
Am J Hum Genet; 1998 Feb; 62(2):286-94. PubMed ID: 9463313
[TBL] [Abstract][Full Text] [Related]
9. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
Sampson JR
Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
[TBL] [Abstract][Full Text] [Related]
10. Critical role of T-loop and H-motif phosphorylation in the regulation of S6 kinase 1 by the tuberous sclerosis complex.
Shah OJ; Hunter T
J Biol Chem; 2004 May; 279(20):20816-23. PubMed ID: 14993219
[TBL] [Abstract][Full Text] [Related]
11. A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation.
O'Connor SE; Kwiatkowski DJ; Roberts PS; Wollmann RL; Huttenlocher PR
Neurology; 2003 Aug; 61(3):409-12. PubMed ID: 12913212
[TBL] [Abstract][Full Text] [Related]
12. The genetic basis of tuberous sclerosis.
Young J; Povey S
Mol Med Today; 1998 Jul; 4(7):313-9. PubMed ID: 9743993
[TBL] [Abstract][Full Text] [Related]
13. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
van Slegtenhorst M; Nellist M; Nagelkerken B; Cheadle J; Snell R; van den Ouweland A; Reuser A; Sampson J; Halley D; van der Sluijs P
Hum Mol Genet; 1998 Jun; 7(6):1053-7. PubMed ID: 9580671
[TBL] [Abstract][Full Text] [Related]
14. Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex.
Yamamoto T; Pipo JR; Feng JH; Takeda H; Nanba E; Ninomiya H; Ohno K
Brain Dev; 2002 Jun; 24(4):227-30. PubMed ID: 12015165
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis: from tubers to mTOR.
Kwiatkowski DJ
Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
[TBL] [Abstract][Full Text] [Related]
16. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions.
Han S; Santos TM; Puga A; Roy J; Thiele EA; McCollin M; Stemmer-Rachamimov A; Ramesh V
Cancer Res; 2004 Feb; 64(3):812-6. PubMed ID: 14871804
[TBL] [Abstract][Full Text] [Related]
18. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.
Xiao GH; Shoarinejad F; Jin F; Golemis EA; Yeung RS
J Biol Chem; 1997 Mar; 272(10):6097-100. PubMed ID: 9045618
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.
Lu Z; Hu X; Li Y; Zheng L; Zhou Y; Jiang H; Ning T; Basang Z; Zhang C; Ke Y
J Biol Chem; 2004 Aug; 279(34):35664-70. PubMed ID: 15175323
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex: from Drosophila to human disease.
Pan D; Dong J; Zhang Y; Gao X
Trends Cell Biol; 2004 Feb; 14(2):78-85. PubMed ID: 15102439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
